1. Introduction

Welcome to Nahda Bulletin of Biomedical Sciences (NBBS), a peer-reviewed medical journal dedicated to advancing research in Experimental and clinical medicine, pharmaceutical sciences, dentistry, and physical therapy. These guidelines provide essential information for authors preparing manuscripts for submission.

2. Scope and Aims

Studies from areas of pharmaceutics, medicinal chemistry, bio-medical experience, clinical pharmacy, biotechnology, pharmacognosy and pharmacology are accepted for publication in case novelty work is present. Submissions on novel applications focusing on general anatomy, histology, microbiology, parasitology, medical pharmacology, obstetrics & gynecology, plastic surgery, and endemic medicine are welcome. Papers dealing with dentistry, oral biology, oral and maxillofacial surgery, oral physiology, dental anatomy, and occlusion are acceptable if the results are expected to attract the interest of readers. Also, manuscripts received from physical therapy for surgery and burn, orthopaedic physical therapy, pediatric physical therapy, women's Health, rehabilitation techniques, and neurorehabilitation are also welcome.

To enable the quick and extensive distribution of research findings to a worldwide audience, articles are published as soon as they are accepted and are publicly accessible on the journal's website.

Human subjects research must have ethical approval and should mention the name of the approving committee, the name of the institution, and the reference number where approval was granted. Animal research must be authorized by their institution's Animal Care and Use Committee, or any similar ethical Committee, and have a reference number.

 

 

The degree of novelty and significance of the research, as well as the degree to which it adds to current knowledge in pharmaceutical and medical sciences, will be considered when deciding whether to publish submitted articles. All contributions to the journal must address the subject of how their proposed methodology compares to previously published approaches.

3. Manuscript types
4. Original Research Articles(Max: [word limit, 8,000 words])

• Structured abstract (250 words)
• Introduction, Methods, Results, Discussion, Conclusion
• References: [ ≤ 90]

1. Review Articles(Max: [e.g., 5,000 words])

• Comprehensive overview of a topic
• Abstract (unstructured, 250 words)
• References: [ ≤ 100]

1. Case Reports(Max: [1,500 words])

• Unique clinical cases with educational value
• Abstract (150 words)
• Introduction, Case Presentation, Discussion
• References: [≤ 20]

1. Short Communications(Max: [ 1,500 words])

• Brief reports on preliminary findings
• Abstract (150 words)
• Concise structure
• References: [≤ 15]

1. Editorials & Letters to the Editor(Max: [1,000 words])

• Commentary on recent articles or medical issues
• No abstract required

4. General Submission Requirements

• Language: English (US/UK spelling, consistent throughout)
• Format: Microsoft Word (docx)
• Font: Times New Roman, 12-point, double-spaced
• Title Page:
• Title (concise and informative)
• Full author names, affiliations, ORCID IDs
• Corresponding author’s email and phone number
• Conflict of interest statement

5. Ethical Considerations

• Human/Animal Studies: Must include ethical approval (IRB/IACUC number) and consent statements.
• Plagiarism: All submissions will be screened for plagiarism (≤20% similarity allowed).
• Authorship: Follow ICMJE guidelines; all authors must have contributed significantly.

• All authors should have made substantial contributions to all of the following:
• The conception and design of the study, or acquisition of data, or analysis and interpretation of data.
• Drafting the article or revising it critically for important intellectual content.
• Final approval of the version to be submitted.
• Authors should appoint a corresponding author to communicate with the journal during the editorial process. All authors should agree to be accountable for all aspects of the work to ensure that the questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
  6. Changes to authorship
• The editors of this journal generally will not consider changes to authorship once a manuscript has been submitted. It is important that authors carefully consider the authorship list and order of authors and provide a definitive author list at original submission.
• The policy of this journal around authorship changes:
• All authors must be listed in the manuscript and their details entered into the submission system.
• Any addition, deletion or rearrangement of author names in the authorship list should only be made prior to acceptance, and only if approved by the journal editor.
• Requests to change authorship should be made by the corresponding author, who must provide the reason for the request to the journal editor with written confirmation from all authors, including any authors being added or removed, that they agree with the addition, removal or rearrangement.

 

7. References

Follow ACS (American Chemical Society) 

e.g. Evans, D. A.; Fitch, D. M.; Smith, T. E.; Cee, V. J. Application of Complex Aldol Reactions to the Total Synthesis of Phorboxazole B. J. Am. Chem. Soc. 2000, 122, 10033-10046.

• Include DOI/PubMed links where available.

8. Peer Review Process

• Double-blind peer review (authors and reviewers remain anonymous).
• Expected review time: [e.g., 4-8 weeks].
• Authors must respond to reviewer comments within [e.g., 3 weeks].

9. Publication Fees (if applicable)

• Article Processing Charge (APC): The publication is free .

10. Funding sources

Authors must disclose any funding sources who provided financial support for the conduct of the research and/or preparation of the article. The role of sponsors, if any, should be declared in relation to the study design, collection, analysis and interpretation of data, writing of the report and decision to submit the article for publication. If funding sources had no such involvement this should be stated in your submission.

11. Declaration of generative AI in scientific writing

The use of generative AI and AI-assisted technologies in scientific writing must be declared by adding a statement at the end of the manuscript when the paper is first submitted. The statement will appear in the published work and should be placed in a new section before the references list. An example:

• Title of new section: Declaration of generative AI and AI-assisted technologies in the writing process.
• Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the published article.

12. Writing and formatting

• File format

We ask you to provide editable source files for your entire submission (including figures, tables, and text graphics). Save files in an editable format, using the extension .doc/.docx for Word files. A  PDF is not an acceptable source file

• Abstract

You are required to provide a concise and factual abstract that does not exceed 250 words. The abstract should briefly state the purpose of your research, principal results, and major conclusions. Some guidelines:

• Abstracts must be able to stand alone as abstracts are often presented separately from the article.
• Abstract should be structured (background, methodology, results, and conclusion)
• Avoid references.

• Keywords
• You are required to provide 1 to 7 keywords for indexing purposes. Keywords should be written in English. Please try to avoid keywords consisting of multiple words (using "and" or "of").
• We recommend that you only use abbreviations in keywords if they are firmly established in the field.
• Highlights
• Highlights that should capture the novel results of your research as well as any new methods used during your study, should consist of 3 to 5 bullet points, each a maximum of 85 characters, including spaces.
• Article structure
  • Divide your article into clearly defined and numbered sections. Number subsections 1.1 (then 1.1.1, 1.1.2, ...), then 1.2, etc.
  • Use the numbering format when cross-reference within your article. Do not just refer to "the text."
  • You may give subsections a brief heading. Headings should appear on a separate line.
•  
• Graphical abstract

You are encouraged to provide a graphical abstract at submission.

The graphical abstract should summarize the contents of your article in a concise, pictorial form that is designed to capture the attention of a wide readership. A graphical abstract will help draw more attention to your online article and support readers in digesting your research. Some guidelines:

• Submit your graphical abstract as a separate file in the online submission system.
• Ensure the image is a minimum of 531 x 1328 pixels (h x w) or proportionally more and is readable at a size of 5 x 13 cm using a regular screen resolution of 96 dpi.
• Our preferred file types for graphical abstracts are TIFF, EPS, PDF or MS Office files.
• Tables
• Tables must be submitted as editable text, not as images. Some guidelines:
• Place tables next to the relevant text or on a separate page(s) at the end of your article.
• Cite all tables in the manuscript text.
• Number tables consecutively according to their appearance in the text.
• Please provide captions along with the tables.
• Place any table notes below the table body.
• Avoid vertical rules and shading within table cells.
• We recommend that you use tables sparingly, ensuring that any data presented in tables is not duplicate results described elsewhere in the article.
• Figures, images, and artwork
• Figures, images, artwork, diagrams and other graphical media must be supplied as separate files along with the manuscript.
• Cite all images in the manuscript text.
• Number the images according to the sequence in which they appear within your article.
• Submit each image as a separate file using a logical naming convention for your files (for example, Figure_1, Figure_2 etc).
• Please provide captions for all figures, images, and artwork.
• All images must have captions. A caption should consist of a brief title (not displayed on the figure itself) and a description of the image. We advise you to keep the amount of text in any image to a minimum, though any symbols and abbreviations used should be explained.

• Generative AI and Figures, images and artwork
• We do not permit the use of Generative AI or AI-assisted tools to create or alter images in submitted manuscripts.
• Supplementary material
• We encourage the use of supplementary materials such as applications, images and sound clips to enhance research. Some guidelines:
• Supplementary material should be accurate and relevant to the research.
• Cite all supplementary files in the manuscript text.
• Submit supplementary materials at the same time as your article. Be aware that all supplementary materials provided will appear online in the same file type as received. These files will not be formatted or typeset by the production team.